aTyr Pharma was founded in 2005 as a spin-off from The Scripps Research Institute. Since then, the company has raised more than $230 million to advance its research and development of medicines targeting the immune-modulatory pathways. aTyr has grown to now have a team of more than 50 researchers and business development professionals.
